Rejuvenation of Aged Muscle Stem Cells Through Exercise
NCT03473288 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2021-06-10
Summary
The proposed study will establish a newly-identified signaling pathway regulating both autophagy and apoptosis in human satellite cells. These findings will allow for novel pharmacological targets in satellite cells to return regenerative capacity to elderly individuals. Up to 80 adults, 21 years of age and greater, will undergo a consent visit followed by three blood draws and muscle biopsy visits- baseline (pre), after the first exercise bout (post-acute), and after the 12 week training program (post-chronic). Blood will be obtained and tested for inflammatory (IL-6/TNF/IL-1) and endocrine markers (Testosterone/Estrogen/Thyroid hormone). As part of the intervention, participants will undergo moderate intensity treadmill exercise three times per week for 10-12 weeks or serve as sedentary controls. Muscle stem cell function will be compared across age groups at each time point using a One Way ANOVA or t test for specific comparisons. An alternative analysis will be a longitudinal design following muscle stem cell function from each individual before and after exercise training. This analysis will be performed with repeated measure ANOVAs. Data will be analyzed using GraphPad Prism 6 statistical software. Significance will be accepted as p\<.05. Thigh Muscle biopsies may result in momentary pain and discomfort, burning or bleeding, numbness, and rarely fainting or infection. The incision site may leave a scar and muscle soreness may be present up to ten days after the biopsy. While the local numbing medicine xylocaine is almost entirely free from allergic properties (such as causing hives), an allergic reaction is possible, and the participant will not be given xylocaine if they have a history of such a reaction. The xylocaine will be given by a small injection into the skin at the site of the muscle biopsy. Risks associated with a standard blood draw include momentary discomfort and/or bruising. In addition, there is a minimal risk of infection, excess bleeding, clotting, and fainting. An exercise program may result in muscle, bone and/or joint soreness, discomfort and/or injury. All collected data will be stored in a locked file to be accessed only by Dr. White and his study staff. Study records that identify subjects will be kept confidential as required by law.
Conditions
- Autophagy and Apoptosis in Human Satellite Cells
Interventions
- BEHAVIORAL
-
Exercise
Participants will undergo supervised exercise 3 times a week for 10-12 weeks.
- BEHAVIORAL
-
Sedentary
Participants will be asked to maintain the sedentary lifestyle that they already have for 10-12 weeks.
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Institute on Aging (NIA)
collaborator NIH - lead OTHER
Principal Investigators
-
James White, PhD · Duke University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-01
- Primary Completion
- 2021-06-06
- Completion
- 2021-06-06
Countries
- United States
Study Locations
More Related Trials
-
External Pharyngeal Exerciser and Dysphagia
NCT05708898 ·Status: RECRUITING ·Phase: NA
-
Muscle Stem Cell Quality in Atrophy
NCT06077734 ·Status: TERMINATED
-
Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
NCT05016908 ·Status: RECRUITING
-
Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2
NCT02704325 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Fatigue in Patients With Amyotrophic Lateral Sclerosis
NCT04468191 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy
NCT01369901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Identification of Relevant Biological, Imaging, Mobility and Clinical Markers for Clinical Research in Sarcopenia
NCT04569487 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study Of Biomarkers Of Skeletal Muscle Atrophy
NCT02839460 ·Status: COMPLETED
-
Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy
NCT02376816 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy
NCT02036463 ·Status: WITHDRAWN ·Phase: PHASE2
-
Electrical Stimulation of Human Myocytes in Microgravity
NCT03665051 ·Status: ACTIVE_NOT_RECRUITING
-
Oxidative Capacity and Exercise Tolerance in Ambulatory SMA
NCT02895789 ·Status: COMPLETED
-
Clinical Trial Readiness for the Dystroglycanopathies
NCT00313677 ·Status: RECRUITING
-
Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT06547216 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy
NCT01093170 ·Status: WITHDRAWN ·Phase: PHASE1
-
Twice Weekly Steroids and Exercise as Therapy for DMD
NCT04322357 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy
NCT00004646 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly
NCT06788236 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT05747924 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial of Exercise in Patients With Spinal Muscular Atrophy (SMA)
NCT01166022 ·Status: COMPLETED ·Phase: NA
-
Investigating Loss of Neuromuscular Junction Transmission Fidelity in Older Adults
NCT04904926 ·Status: COMPLETED
-
Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States
NCT06747273 ·Status: TERMINATED ·Phase: PHASE1
-
Mechanisms and Treatment of Exercise Intolerance and Persistent Fatigue in Spinal Muscular Atrophy
NCT05518773 ·Status: COMPLETED
-
Clinical Procedures to Support Research in ALS
NCT03489278 ·Status: RECRUITING
-
Evaluation of Home Based Assessments on Participants With DMD
NCT05657938 ·Status: COMPLETED